Navigation Links
Molecular mechanism of anaphylactic shock decoded

Researchers at Heidelberg University have found a molecular mechanism for anaphylactic shock. The activation of specific proteins in the cell walls of small blood vessels plays an important role. Suppressing the respective genes protects mice from the potentially fatal reactions of the immune and circulatory systems (anaphylactic shock) without disrupting circulatory regulation. This paves the way for the development of new drugs for the treatment and prevention of anaphylactic shock.

The study by Professor Dr. Stefan Offermanns, Medical Director of the Institute of Pharmacology at Heidelberg University, and his study group in cooperation with colleagues at the German Cancer Research Center in Heidelberg as well as at Frankfurt University and the Max Planck Institute in Bad Nauheim was published online in "The Journal of Experimental Medicine".

Anaphylactic shock is an acute, life-threatening allergic reaction, usually brought on by medication, insect stings, or other allergens, which has become more frequent in recent decades. In sensitized persons, the presence of the allergen leads to the release of various substances (mediators) from immune cells in the blood. These mediators, e.g. histamine or leukotriene, cause an abrupt drop in blood pressure, lowering of body temperature, arrhythmia, respiratory distress, and acute reactions in stomach, bowels and skin. The combination of reactions leads to the life-threatening situation known as anaphylactic shock.

The mediators develop their effect via so-called G protein-coupled receptors that are found on different body cells, among others, in the walls of blood vessels. They trigger signals in the cells that then cause the typical symptoms of an anaphylactic reaction. "In the genetic mouse model, we showed that surprisingly, selective suppression of the genes coding for the G proteins Gq and G11 in vessel walls protected the animals from the most severe anaphylactic reactions", stated Professor Offermanns. Now the road is open for developing and testing substances that could be used directly to inhibit the triggering mechanism.


Contact: Dr. Stefan Offermanns
University Hospital Heidelberg

Related biology news :

1. New molecular regulators of hyperthyroidism and goiter
2. Carnegie Mellon scientists investigate initial molecular mechanism that triggers neuronal firing
3. UC health news: molecular pathway may predict chemotherapy effectiveness
4. New molecular clock from LLNL and CDC indicates smallpox evolved earlier than believed
5. Story ideas from Molecular & Cellular Proteomics
6. Lets talk -- new paradigms in the research of the biomolecular composition of water
7. Scientists unveil structure of molecular target of many drugs
8. Potential new therapeutic molecular target to fight cancer
9. NIH selects LIAI for major study on allergy molecular causes and possible treatments
10. Pennsylvania Hospital surgeon receives grant to develop molecular cardiac surgery
11. Leading cause of death in preemies might be controlled by resetting a molecular switch
Post Your Comments:
Related Image:
Molecular mechanism of anaphylactic shock decoded
(Date:10/29/2015)... MINNETONKA, Minn. , Oct. 29, 2015   ... that supports the entire spectrum of clinical research, is ... the Minnesota High Tech Association (MHTA) as one of ... in the "Software – Small and Growing" category. The ... and individuals who have shown superior technology innovation and ...
(Date:10/29/2015)... October 29, 2015 NXTD ... company focused on the growing mobile commerce market ... that StackCommerce, a leading marketplace to discover and ... Wocket® smart wallet on StackSocial for this holiday ... or the "Company"), a biometric authentication company focused ...
(Date:10/26/2015)... , October 26, 2015 ... --> adds Biometrics Market ... 2021 as well as Emerging Biometrics ... reports to its collection of IT ... . --> ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... IN (PRWEB) , ... November 24, 2015 , ... The ... newest Special Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to represent ... the last few years. Many AMA members have embraced this type of racing and ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... today that the remaining 11,000 post-share consolidation (or ... Warrants (the "Series B Warrants") subject to the ... on November 23, 2015, which will result in ... giving effect to the issuance of such shares, ...
(Date:11/24/2015)... BC (PRWEB) , ... November 24, 2015 , ... ... our customer, OrthoAccel® Technologies, Inc., on being named to Deloitte's 2015 Technology Fast ... Technologies’ Texas facility, OrthoAccel manufactures AcceleDent®, a FDA-cleared, Class II medical device that ...
(Date:11/24/2015)...  PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ) today ... and chief executive officer, will present at the 27 th ... New York City . The presentation will be ... at 9:30 a.m. EST. and go ... least 15 minutes prior to the presentation to allow for ...
Breaking Biology Technology: